X @Bloomberg
Lilly halts a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons https://t.co/isjH65RANR ...
Lilly halts a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons https://t.co/isjH65RANR ...